Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus oxycodone continuous subcutaneous infusion in terminal patients with reduced renal function
2017-002192-25Phase 4Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pain comparing Morphine CSCI with Oxycodone CSCI (2 arms). Primary endpoint: Occurrence of delirium. Started Jul 2017; status: terminated.
02
Drugs
morphineoxycodone
03
Conditions
pain
Beyond the preview
Go deeper on 2017-002192-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002192-25.